Header Logo

Connection

Celalettin Ustun to Alemtuzumab

Back to Details
This is a "connection" page, showing publications Celalettin Ustun has written about Alemtuzumab.
Celalettin Ustun
Connection Strength
0.040
Alemtuzumab
  1. Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. Blood Adv. 2018 11 13; 2(21):2922-2936.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.